XtalPi is a biopharmaceutical technology firm that is revolutionizing the sector's approach to pharmaceutical research and innovation using its Advanced Digital Drug Discovery and Development (AD4) platform. Incorporating interconnected quantum mechanics, artificial intelligence, and high-capacity cloud computing algorithms, XtalPi's AD4 platform delivers precise forecasts on the physical and chemical characteristics of small-molecule candidates for medication design, solid-form selection, and other crucial facets of pharmaceutical development.
Xtalpi
Headquarters
United States of America